MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

An Exploration of the Psychosocial Impact of Receiving Treatment at a Sialorrhea Clinic for People with Parkinson’s Disease

M. Vazirian Zadeh, J. Adenwalla, C. Marquis, B. Mohamed, C. Thomas, R. Lewis-Morton (Penarth, United Kingdom)

Meeting: 2023 International Congress

Abstract Number: 1841

Keywords: Parkinson’s, Sialorrhea

Category: Allied Healthcare Professionals

Objective: To explore the psychosocial impact (impact on quality of life, self-compassion, self-esteem & shame) of receiving treatment for sialorrhea in people with Parkinson’s.

Background: Sialorrhea, or drooling, is one of the most debilitating complaints reported in people with Parkinson’s (Isaacson et al 2020). Sialorrhea in Parkinson’s has been linked with a reduced quality of life, low self-esteem, embarrassment, shame and social isolation (Kalf et al 2007). Cardiff and Vale University Health Board runs a clinic offering Xeomin injections used to treat sialorrhea. There is currently limited evidence highlighting the psychosocial impact of sialorrhea and of treating sialorrhea.

Method: Six male patients (age ranging 67 – 81; disease duration between 6 – 20 years) received a Xeomin injection at a Parkinson’s Sialorrhea clinic. Patients were evaluated before and 2-weeks after receiving a Xeomin injection, using the Warwick-Edinburgh Mental Wellbeing Scale, Sussex Oxford Compassion Scale, and Rosenberg Self-esteem Scale. Two scales used routinely by the Sialorrhea Clinic were also administered: the Drooling Severity and Frequency Scale, and the ‘Best Imaginable Health State’ thermometer 0-100. Semi-structured interviews 2-weeks post-Xenomin injection were also completed with the patients and carers.

Results: Thematic analysis revealed the following themes:  

(1) Reduction of anxiety in relation to social situations 

“It feels easier that he is not so anxious about it [drooling] going out shopping and we been out for lunch a couple times and he didn’t seem so anxious” (carer) 

(2) Increased social connectedness 

“It has had quite a major effect on my wellbeing, I’ve been able to take part in more conversations, which means an awful lot to me” 

(3) Increased confidence 

“I found before going out was difficult because… but now I feel a bit more confident”.

Conclusion: This evaluation highlights the psychosocial impact of receiving treatment for sialorrhea for people with Parkinson’s and their carers. This includes reduced anxiety, increased social connectedness and increased confidence. This in turn has a positive impact on the quality of life for patients and carers. We hope this evaluation increases awareness of the psychosocial impact of sialorrhea for people with Parkinson’s and provides rationale to continue resourcing this valuable service.

To cite this abstract in AMA style:

M. Vazirian Zadeh, J. Adenwalla, C. Marquis, B. Mohamed, C. Thomas, R. Lewis-Morton. An Exploration of the Psychosocial Impact of Receiving Treatment at a Sialorrhea Clinic for People with Parkinson’s Disease [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/an-exploration-of-the-psychosocial-impact-of-receiving-treatment-at-a-sialorrhea-clinic-for-people-with-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/an-exploration-of-the-psychosocial-impact-of-receiving-treatment-at-a-sialorrhea-clinic-for-people-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley